Age, period and cohort effects on mortality from cervical cancer in Colombia between 1985 and 2014.
Abstract
Objective:
To analyze cervix cancer mortality in Colombia based on age, period, and cohort effects.
Methods:
The mortality and population data were taken from the official databases of the National Administrative Department of Statistics, DANE. Five models were adjusted, and the significance of the effects was obtained by comparing them through the likely ood ratio test.
Results:
The age-adjusted mortality rate in deaths was 15.09/per 100,000 women in 1985-1989 and 10.21 in 2010-2014. The annual percentage average change was -1.45% (95% CI: -1.57% to -1.34%). Age, period, and cohort effects were found.
Conclusions:
Demographic factors could explain the behavior of cervical cancer mortality in Colombia and the establishment of public health measures in the last two decades.
Authors
Downloads
Keywords
- Cohort Effect
- Uterine Cervical Neoplasms
- Linear Models
- Birth Cohort
- Cause of Death
- Population Forecast
- Age Factors
- Risk Factors
- Health Services Accessibility
References
International Agency for Reseach on Cancer. New Global Cancer Data: Globocan. [Online].; 2020 [cited 2022. Available from: https://gco.iarc.fr/today.
International Agency for Research on Cancer. Global Cancer Observatory: Cancer Over Time. [Online].; 2020 [cited 2022. Available from: https://gco.iarc.fr/overtime/en.
Ahmedin J, Bray F, Center M, Ferlay J, Ward E. Global cancer statistics. CA: A Cancer Journal for Clinicians. 2011; 61(2): p. 69-90. https://doi.org/10.3322/caac.20107 PMid:21296855
Pan American Health Organization (PAHO). Cancer in the Americas: Country Profiles. [Online].; 2013 [cited 2020. Available from: http://www.paho.org/hq/index.php?option=com_content&view=article& id=9010:cancer-in-the-americas-country-profiles-2013&catid=1872:nmh-cancer- content&Itemid=40084〈=en.
Bosetti C, Malvezzi M, Chatenoud L, Levi F, La Vecchia C. Trends in cancer mortality in the Americas, 1970-2000. Annals of Oncology. 2005; 16(3): p. 489-511. https://doi.org/10.1093/annonc/mdi086 PMid:15668262
Pardo C, de Vries E, Buitrago L, Gamboa O. Atlas de mortalidad por cáncer en Colombia Bogotá: Ministerio de Protección Social. Instituto Nacional de Cancerología.; 2017.
Piñeros M, Gamboa O, Hernández-Suárez G, Pardo C, Bray F. Patterns and trends in cancer mortality in Colombia. Cancer Epidemiology. 2013 Jun; 37(3): p. 233-239. https://doi.org/10.1016/j.canep.2013.02.003 PMid:23499325
Piñeros M, Hernández G, Bray F. Incresing Mortality Rates of Common Malignancies in Colombia. Cancer. 2004; 101(10): p. 2285-2292. https://doi.org/10.1002/cncr.20607 PMid:15382090
Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global Cancer Statistics. CA: A Cancer Journal for Clinicians. 2004; 61(1): p. 69-90. https://doi.org/10.3322/caac.20107 PMid:21296855
Carstensen B. Age-period-cohort models for the Lexis diagram. Statistics in Medicine. 2007; 26(15): p. 3018-3045. https://doi.org/10.1002/sim.2764 PMid:17177166
Holford T. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annual Review of Public Health. 1991; 12(1): p. 425-457. https://doi.org/10.1146/annurev.pu.12.050191.002233 PMid:2049144
Goss P, Lee B, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, StLouis J, et al. Planning cancer control in Latin America and the Caribbean. The Lancet Oncology. 2013; 14(5): p. 391-436.
Bray F, Jemal A, Gray N, Ferlay J, Forman D. Global Cancer Transitions Acoording to the Huma Development Index (2008-2030): a population based study. The Lancet Oncology. 2012; 13(8): p. 790-801. https://doi.org/10.1016/S1470-2045(12)70211-5
Parkin D. The global health burden of infection-associated cancer in the year 2002. International Journal of Cancer. 2006; 118(12): p. 3030-3044. https://doi.org/10.1002/ijc.21731 PMid:16404738
Mathew A, George P. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide. Asian Pac J Cancer Prev. 2009; 10(4): p. 645-650.
DANE. Departamento Administrativo Nacional de Estadística. Demografía y población. [Online].; 2005.
World Health Organization. Classifications. International Classification of Diseases (ICD). [Online].; 1998 [cited 2014 06 29. Available from: http://www.who.int/classifications/icd/en/.
National Cancer Institute. Surveillance, Epidemiology, and End Results Program. [Online].; 2018 [cited 2018 01 22. Available from: https://seer.cancer.gov/stdpopulations/stdpop.19ages.html.
Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. Estimates of worlwide burden of cancer in 2008:GLOBOCAN 2008. Int J Cancer. 2010; 127(12): p. 2893-2917. https://doi.org/10.1002/ijc.25516 PMid:21351269
Sierra MS, Soerjomataram I, Antoni S, Laversanne M, Piñeros M, de Vries E, et al. Cancer patterns and trends in Central and South America. Cancer Epidemiology. 2016; 44(1): p. S23-S42. https://doi.org/10.1016/j.canep.2016.07.013 PMid:27678320
Murillo R, Herrero R, Sierra M, Forman D. Cervical cancer in Central and South America: Burden of disease and status of disease control. Cancer Epidemiology. 2016; 44(1): p. S121-S130. https://doi.org/10.1016/j.canep.2016.07.015 PMid:27678314
Almonte M, Ginesa A, Molano M, Carcamo C, García PJ, Pérez G. Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean. Vaccine. 2008 Aug; 26(Suplemento: 11). https://doi.org/10.1016/j.vaccine.2008.06.008 PMid:18945400
Molano M, Posso H, Méndez F, Murillo R, Van den Brule A, Ronderos M, et al. Historia natural de la infección por el virus del papiloma humano en una cohorte de Bogotá. Rev Colomb Cancerol. 2005; 9(4): p. 209-226.
Vorsters A, Bosch F, Bonanni P, Franco E, Baay M, Simas C, et al. Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report. BMC Proceedings. 2020; 14(8): p. 1-13. https://doi.org/10.1186/s12919-020-00192-2 PMid:32577128 PMCid:PMC7307134
Garcés-Palacio I, Altarac M, Kirby R, McCLure L, Mulvihill B, Scarinci I. Contribution of health care coverage in cervical cancer screening follow-up: findings from a cross-sectional study in Colombia. Int J Gynecol Cancer. 2010; 10(7): p. 1232-1239. https://doi.org/10.1111/IGC.0b013e3181e8dfb8 PMid:21495237
Ministerio de la Protección Social. Acuerdo número 282 de 2004. 2004 Diciembre..
Ministerio de Salud y Protección Social. Socialización del informe final de evaluación de necesidades para la ampliación del Convenio Marco del Control del Tabaco. Cifras oficiales para Colombia. [Online].; 2016 [cited 2022 agosto. Available from: https://www.minsalud.gov.co/Documents/General/Cifras-tabaco-Colombia.pdf.
P.G. R, Bundy BN, Watkins EB, Deppe G, Maiman MA, Clarke-Pearson DL, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999; 340(15): p. 1144-53. https://doi.org/10.1056/NEJM199904153401502 PMid:10202165
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. The Lancet. 2019; 393(10167): p. 169-182. https://doi.org/10.1016/S0140-6736(18)32470-X
Galán Ch G. 50 años de la píldora anticonceptiva. Revista Chilena de obstetricia y ginecología. 2010; 75(4): p. 217-220. https://doi.org/10.4067/S0717-75262010000400001
Pñeros M, Pardo C, Gamboa O, Hernández G. Atlas de Mortalidad por cáncer en Colombia: Instituto Nacional de Cancerología. Ministerio de la Protección Social.; 2010.
Congreso de la República. Ley 1626 de 2013. 2013..
Ministerio de Salud y Protección Social. Resolución 3280 de 2018. 2018..
Roselli D, Hernández-Galvis J. El impacto del envejecimiento sobre el sistema de salud colombiano. Salud Pública de México. 2016; 58(6). https://doi.org/10.21149/spm.v58i6.7880 PMid:28225930
Bruni L AGSBMMCJGDMJBFdSS. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Colombia. Summary Report. [Online].; 2021 [cited 2022 junio. Available from: https://hpvcentre.net/statistics/reports/COL.pdf?t=1655417342699.
Copyright (c) 2022 Universidad del Valle
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use